| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.36 | 0.3 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.25 | 0.03 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |